A visual evoked potential (VEP) test is one test that a doctor may use to diagnose multiple sclerosis and monitor disease treatment and progression. Your brain and spinal cord make up your central ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS). Made by Roche, the test is ...

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...

The eSDMT enables frequent remote cognitive assessments for pwMS, shifting from cross-sectional to longitudinal evaluation frameworks. The study showed strong concurrent validity and test-retest ...

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...

Misdiagnoses of multiple sclerosis (MS) represent one of the prominent challenges in MS for patients, clinicians, and researchers. A variety of factors influence misdiagnosis, including testing ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other neurodegenerative ...

Add Yahoo as a preferred source to see more of our stories on Google. A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.